Cyanta Drug Development Services - - BioPharm International

ADVERTISEMENT

Cyanta Drug Development Services

BioPharm International
Volume 19, Issue 12

Corporate Description



Cyanta Drug Development Services is solely dedicated to assisting pharmaceutical, biotechnology and medical device companies achieve their regulatory registration goals through extensive analytical testing and support services. The spin of Chemir Analytical Services' pharmaceutical group, we are outfitting a new facility with state-of the-art instrumentation and systems to continue to meet expectations of compliance and timely service. Our background of solving challenging analytical problems and providing drug development services has enabled us to become a premiere drug development partner.

Markets Served

We help large to virtual pharmaceutical and medical device companies.

Products and Services

We specialize in non-routine analysis for drug substances and excipients, oral dosages (tablets, capsules), topical dosages (creams, ointments, lotions), liquid dosages (injectables, suspensions), inhalation dosages (MDI, DPI, Nasal), and medical devices (implantables, flexible tubing, containers and protective devices).



Technical Services: Cyanta has numerous capabilities to support your drug and medical device development efforts. These services include method development, method validation, stability studies under ICH conditions, degradation studies, dissolution testing, release testing, extractables/leachables programs for medical devices, custom synthesis, reference standard characterization, formulation support, consulting services and variety of other services designed to meet your regulatory goals in a timely manner.

Facilities

Centrally located in suburban St. Louis, MO, our facility is FDA registered, cGMP/GLP compliant and DEA licensed. Instrumentation includes LC/MSn, HPLC, GPC, ICP, DSC, FT-IR, SEM/EDXA, GC/MS, NMR, physical-testing equipment for medical devices and more. We are scheduled to move into a newly renovated, state- of-the-art 25,000-sq. ft. facility in early 2007, adjacent to our current location.

CYANTA DRUG DEVELOPMENT SERVICES
2672 Metro Blvd
Maryland Heights, MO
63043

TELEPHONE
800.659.6059

FAX
314.291.6630

EMAIL

WEB ADDRESS
http://www.cyanta.com/

EMPLOYEES
52

FOUNDED
1959

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here